# United Bancorp Inc: overview UBCP · Nasdaq · CIK 731653 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ubcp.md) · [Financials](/companies/ubcp/financials.md) · [Filings](/companies/ubcp/filings.md) · [Insiders](/companies/ubcp/insiders.md) Latest reported revenue: [$721.0k](/filings/0001104659-21-138777.md) for Q3 FY2021, three months to 2021-09-30, from the 10-Q filed Nov 15, 2021 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001104659-21-138777). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.31](/filings/0001104659-26-030899.md) | [0.31](/filings/0001104659-26-030899.md) | [0.32](/filings/0001104659-26-060924.md) | [0.33](/filings/0001104659-26-094756.md) | [0.34](/filings/0001104659-26-030899.md) | [0.35](/filings/0001104659-26-030899.md) | [0.33](/filings/0001104659-26-060924.md) | [0.36](/filings/0001104659-26-094756.md) | | Free cash flow | $k | [(1,681) d](/filings/0001104659-25-110121.md) | [697 d](/filings/0001104659-26-030899.md) | [(594)](/filings/0001104659-26-060924.md) | [1,464 d](/filings/0001104659-26-094756.md) | [(367) d](/filings/0001104659-25-110121.md) | [(1,825) d](/filings/0001104659-26-030899.md) | [(1,778)](/filings/0001104659-26-060924.md) | [(140) d](/filings/0001104659-26-094756.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.62](/filings/0001410578-23-000281.md) | [1.50](/filings/0001410578-24-000239.md) | [1.57](/filings/0001410578-25-000351.md) | [1.27](/filings/0001104659-26-030899.md) | [1.34](/filings/0001104659-26-030899.md) | | Free cash flow | $k | [7,415](/filings/0001410578-23-000281.md) | [7,970](/filings/0001410578-24-000239.md) | [8,382](/filings/0001410578-25-000351.md) | [(1,247)](/filings/0001104659-26-030899.md) | [(1,322)](/filings/0001104659-26-030899.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ubcp/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.8m | 112,925 | | Added +22,016 | | [Commonwealth Financial Services, LLC](/funds/1536755.md) | 2026-06-30 | $1.4m | 89,160 | | Added +1,805 | | [Post Resch Tallon Group Inc.](/funds/2054476.md) | 2026-06-30 | $884.1k | 55,675 | | Added +12,500 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $869.9k | 54,762 | | Added +5,093 | | [Stratos Wealth Partners, LTD.](/funds/1612865.md) | 2026-06-30 | $774.6k | 48,775 | | New +48,775 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $722.7k | 45,509 | | Added +353 | | [Bahl & Gaynor LLC](/funds/872259.md) | 2026-06-30 | $636.0k | 40,050 | | Unchanged | | [Vawter Financial, Ltd.](/funds/1974403.md) | 2026-06-30 | $577.9k | 36,392 | | Added +63 | | [Appalachian Capital Management Ltd](/funds/2111450.md) | 2026-06-30 | $530.2k | 33,387 | | Added +15 | | [WESBANCO BANK INC](/funds/877134.md) | 2026-06-30 | $498.0k | 31,360 | | Unchanged | ## Recent filings [All 560 filings](/companies/ubcp/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-20 | 15:29 ET | [8-K](/filings/0001104659-26-099202.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-099202 | | 2026-08-12 | 14:09 ET | [10-Q](/filings/0001104659-26-094756.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094756 | | 2026-07-24 | 10:03 ET | [8-K](/filings/0001104659-26-086543.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-086543 | | 2026-05-14 | 12:06 ET | [10-Q](/filings/0001104659-26-060924.md) | Quarterly report, period 2026-03-31 | 0001104659-26-060924 | | 2026-05-07 | 16:54 ET | [8-K](/filings/0001104659-26-057249.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-057249 | | 2026-04-23 | 13:54 ET | [8-K](/filings/0001104659-26-047551.md) | 5.07 Shareholder vote results | 0001104659-26-047551 | | 2026-04-23 | 13:54 ET | [8-K](/filings/0001104659-26-047550.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-047550 | | 2026-03-19 | 18:00 ET | [10-K/A](/filings/0001104659-26-031372.md) | Annual report, amended, period 2025-12-31 | 0001104659-26-031372 | | 2026-03-18 | 16:14 ET | [DEF 14A](/filings/0001104659-26-030925.md) | Proxy statement, period 2026-04-22 | 0001104659-26-030925 | | 2026-03-18 | 16:09 ET | [10-K](/filings/0001104659-26-030899.md) | Annual report, period 2025-12-31 | 0001104659-26-030899 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-030899.md), filed Mar 18, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 731653 - Tickers: UBCP - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: OH - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.